Seeking Alpha

European regulators grant marketing authorization to Bydureon, a collaboration between Alkermes...

European regulators grant marketing authorization to Bydureon, a collaboration between Alkermes (ALKS), Eli Lilly (LLY) and Amylin (AMLN) for the treatment of type 2 diabetes. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|